News & Updates
Filter by Specialty:
Biologics prevent infection-related hospitalization in IBD patients with comorbidity
Treatment with vedolizumab or ustekinumab leads to reduced rates of infection-related hospitalization compared with antitumour necrosis factor-α antagonists (anti-TNF) among adults with inflammatory bowel disease (IBD) initiating biologic therapy and with high comorbidity burden, reports a recent study.
Biologics prevent infection-related hospitalization in IBD patients with comorbidity
20 Nov 2022
Could a single screening colonoscopy prevent CRC?
Results of the NordICC* trial from Europe, presented at the United European Gastroenterology Week (UEG 2022), have hinted at the benefit of a single screening colonoscopy in preventing colorectal cancer (CRC).
Could a single screening colonoscopy prevent CRC?
16 Nov 2022
COVID-19 infection affects faecal microbiota and this condition may persist long after recovery from the disease.
COVID-19 infection is associated with faecal microbiota dysbiosis*, especially those that cause more severe disease, says a prominent researcher. However, there is ambiguity as to whether it is a meaningful association or an epiphenomenon**.
